SEC Charges Texas Resident With Insider Trading
August 12, 2025
August 12, 2025
WASHINGTON, Aug. 12 -- The Securities and Exchange Commission issued the following litigation release (No. 3:25-cv-02101; N.D. Tex. filed Aug. 7, 2025) involving Bruce Cameron Conway:
* * *
On August 7, 2025, the Securities and Exchange Commission filed charges against Bruce Cameron Conway, a resident of Dallas, Texas, for insider trading in advance of the August 24, 2020 announcement that Cancer Genetics, Inc. would merge with a privately held biotechnology company.
* * *
On August 7, 2025, the Securities and Exchange Commission filed charges against Bruce Cameron Conway, a resident of Dallas, Texas, for insider trading in advance of the August 24, 2020 announcement that Cancer Genetics, Inc. would merge with a privately held biotechnology company.